Navigation Links
MediGain Announces Release of New Oncology Analytics Solution
Date:1/4/2012

DALLAS, Jan. 4, 2012 /PRNewswire-iReach/ -- MediGain, a national leader in revenue cycle management and financial analytics, today announced the release of OptimOncology, a financial analytics tool that correlates all drug and financial costing for office-based oncology practices.  This unique technology aggregates financial, clinical and drug utilization data and provides measurable results for oncology practices.

"Drug costs are one of the top concerns in all oncology practices.  Reimbursements from the government and private payers continue to decrease.  Our goal is to provide premium care for our patients with the best possible outcomes.  MediGain's solutions help us do just that," stated California oncologist James Berenson, MD. 

In an industry where costs are soaring and payer reimbursements are declining, the prosperity, and sometimes survival, of a practice can depend upon the availability of quality information.  For oncology practices, the OptimOncology solution means physicians have quick access to financial analysis and clinical decision support that has never before been available in an office-based setting. The OptimOncology technology allows them to make more timely and profitable business decisions. 

"We are very excited to have the first true analytics technology for office-based oncology practices," stated Greg Hackney, CEO of MediGain. "This will be a revolutionary milestone in the evolution of oncology practices.  Physicians will be able to quickly understand how the current and future costs and reimbursements will affect their financial performance."

OptimOncology is offered on a web-based analytics platform and supported by client service teams with deep healthcare expertise, allowing the physician to have instant access to the analysis and trends of his practice.

About MediGain:  MediGain is a national Revenue Cycle Management and Financial Analytics company devoted to improving billing, reimbursement collections, and outcomes for healthcare providers and the patients they serve. With over 300 employees, MediGain provides solutions for physician groups, provider networks, and hospitals enabling them to reach their maximum potential through improved operational, financial, and clinical outcomes. 

Media Contact: Corianne Standerfer MediGain, 972-675-7344, corianne.standerfer@medigain.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MediGain
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
2. OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology
3. Echo Therapeutics Announces $3.6 Million Warrant Exercises
4. Shield HealthCare Announces Caregiver Story Contest Winners
5. PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer
6. Radient Pharmaceuticals Announces Reverse Stock Split
7. ViroPharma Announces Appointment of Julie H. McHugh to Board of Directors
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at J.P. Morgan Healthcare Conference
9. Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
11. Cyberonics Announces FDA Approval of Re-Designed AspireHC™ Generator for VNS Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has issued an important reminder ... at their worksites. Employers with workers exposed to high temperatures should establish ...
(Date:6/27/2016)... ... , ... "FCPX editors can now reveal their media with growing colorful split ... Austin - CEO of Pixel Film Studios. , ProSlice Color brings the split ... now reveal the media of their split screens with growing colorful panels. , ProSlice ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/27/2016)... ... 27, 2016 , ... A revolution is underway. Brooklyn-based ... experience for the millions of people who require these medical transport services annually. ... through the use of technology. Now, SmartEMS has put forth an industry-changing app ...
Breaking Medicine News(10 mins):